The association between TMAO and Type 2 diabetes was proposed based on multiple mechanisms, including elevated fasting insulin levels and HOMA-IR, aggravating impaired glucose tolerance, and promoting adipose tissue inflammation [8]. This evidence concerns the gene INS and type 2 diabetes mellitus.